Clinical Trials in Johns Creek

PAY MEMBER DUES

JCHA Calendar - NEW

Member Benefits and Tools

Member Update Info Form

Membership Info Brochure

Membership Application

View the JCHA Newsletter

Active Clinical Trials in Johns Creek

The following is a list of active clinical trials being conducted in the Johns Creek area by JCHA members. Please e-mail Lee Herman, MD with changes to the list. Please contact the investigator directly if you have any patients to enroll, or if you have any questions.

Johns Creek Primary Care Research Department
Comprehensive Neurology Specialists Research Department
Georgia Neurology & Sleep Medicine Associates - NEW
Albert Johary, MD Research Department

Johns Creek Primary Care Research Department back to top

Principle Investigator: Lee Herman, MD - drleeherman@yahoo.com
Research Coordinator: Tabby Sapp - tsapp@gmail.com, 678-205-3456

1. Type 2 Diabetes:
A research study with a pharmaceutical company evaluating the effects of an investigational drug for Type 2 Diabetes is being conducted. You must be:

be between the ages of 18 and 80
have been treated for type 2 diabetes with one or more anti-diabetic medications including oral agents, Exenatide (Byetta), or Pramlintide (Symlin)
have NOT used insulin to control their diabetes
are not a smoker

2. Osteoarthritis:
There may be a new pain medication for Osteoarthritis. If you have low back, hip, or knee pain from Osteoarthritis, you may qualify for a clinical research study of an investigational pain medication. Participants will receive at no cost, study related:

Physical exams
Laboratory tests
Pain medication

3. Osteoarthritis:
Bothered by Arthritis? Concerned about Heart Disease? We are conducting a research study of 3 approved medications commonly used to treat pain due to osteoarthrits (OA) or rheumatoid arthritis (RA) in people who also have or are at high risk for heart disease. Qualified participants will receive study-related medical care, regular study check-ups, and study medication at no charge. To qualify you must:

Be 18 years of age or older
Have had osteoarthritis or rheumatoid arthritis for your pain for at leats 6 months
Have or be at high risk for heart disease, which includes a history of heart attack, stroke, or diabetes

Comprehensive Neurology Specialists Research Department back to top

Principle Investigator: Mark I. Harris, MD
Researchers: Krithika Praveen, MS and Erika Tequia
Office: 770-454-4695
E-mail: Research1@cnsneurology.com and Research2@cnsneurology.com

Research Studies:

1. A 76 –week prospective, open–label multicenter study to evaluate the long-term effect of Exelon capsule and transdermal patch on worsening of the underlying motor symptoms of PD in patients with mild to moderately severe dementia associated with Parkinson’s disease

2. A Prospective Randomized 12- Week controlled study of Visual Field Change in Subjects with Partial Seizures receiving Pregablin or Placebo

3. An Open–label, long-term follow-up study with Keppra XR for treatment of partial onset seizures.

Georgia Neurology & Sleep Medicine Associates back to top

Principle Investigator: David Lesch MD

Clinical Trial Manager: Tricia Seely-Dalley NP-C

Active Clinical Trials

1. Excessive Sleepiness Associated with Mild or Moderate Closed Traumatic Brain Injury (TBI)

TBI within the last 4 years Excessive Daytime Sleepiness began within one year of TBI

Armodafinil vs placebo

2. Refractory partial seizures with and without secondary generalization –adjunctive therapy

No 25 day seizure free period No status epilepticus in the last year

Study drug vs placebo There is a open label extension trial patients may elect to rollover into

3. Efficacy trial of pregabalin as monotherapy in the treatment of patients with partial seizures who are not well controlled on their current antiepileptic drug treatment.

Partial seizures with and without secondary generalization

No 4 week seizure free period >4 partial seizures in 8 weeks A extension trial is also available

Please call or email to find out more information:

Tricia Seely-Dalley NP-C

Clinical Trial Manager/ Nurse Practitioner

tdalley@ganeurosleep.com

770-814-9455

Albert Johary, MD Research Department back to top

Principle Investigator: Albert Johary, MD albertjohary@msn.com

1. Celebrex vs. OTHER (Mobic, etc.) in patients with chronic osteoarthritis requiring daily NSAID treatment. Patients must not be allergic to Sulfa.

2. Testosterone gel vs. Placebo in Hypogonadal males.

3. Actos plus Glucophage vs. Glucophage plus a new DPP4-inhibitor in patients with uncontrolled diabetes.

4. Observational trial involving uncontrolled hypertensives where they receive a home blood pressure monitor to monitor their own blood pressure to see if they can acheive better control when they have the ability to monitor their own blood pressures.